Specialty pharma company Acerus Pharmaceuticals (TSX:ASP) produced soft results in its third quarter, according to analyst André Uddin of Mackie … [Read more...] about Acerus Pharmaceuticals has huge upside, Mackie Research says
Life Sciences
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
Tetra Bio-Pharma acquisition of Panag Pharma gets thumbs up at Paradigm
A new acquisition for Tetra Bio-Pharma (Tetra Bio-Pharma Stock Quote, Chart: TSX:TBP) turns the company into a vertically integrated pharma company, … [Read more...] about Tetra Bio-Pharma acquisition of Panag Pharma gets thumbs up at Paradigm
Acerus Pharma’s C-suite shakeup is a positive, Mackie Research says
Specialty pharma company Acerus Pharmaceuticals (Acerus Pharmaceuticals Stock Quote, Chart TSX:ASP) has announced a changeup in the CFO role effective … [Read more...] about Acerus Pharma’s C-suite shakeup is a positive, Mackie Research says
Time to get out of Reliq Health, Peter Imhof says
Reliq Health Technologies (Reliq Health Stock Quote, Chart TSXV:RHT, OTC:RQHTF) is in dire straits as the healthcare software company faces scrutiny … [Read more...] about Time to get out of Reliq Health, Peter Imhof says
Acerus Pharmaceutical has 189 per cent upside, Mackie Research says
Specialty pharma company Acerus Pharmaceutical (Acerus Pharma Stock Quote, Chart: TSX:ASP) has made the leap into the cannabis sector with its THC … [Read more...] about Acerus Pharmaceutical has 189 per cent upside, Mackie Research says
Cipher Pharmaceuticals has a 208 per cent upside, Echelon Wealth says
Specialty pharma company Cipher Pharmaceuticals (Cipher Pharma Stock Quote, Chart: TSX:CPH) just announced the Canadian launch of its atrial … [Read more...] about Cipher Pharmaceuticals has a 208 per cent upside, Echelon Wealth says
Antibe Therapeutics has huge upside, Echelon Wealth says
Antibe Therapeutics (Antibe Therapeutics Stock Quote, Chart TSXV:ATE) may keep trading sideways for a while yet but the drug developer’s ATB-346 … [Read more...] about Antibe Therapeutics has huge upside, Echelon Wealth says
ProMetic Life Sciences has a huge upside, Paradigm Capital says
Biopharmaceutical company ProMetic Life Sciences (ProMetic Life Sciences Stock Quote, Chart TSX:PLI) has received the green light from the US FDA … [Read more...] about ProMetic Life Sciences has a huge upside, Paradigm Capital says
Reliq Health has 155 per cent upside, PI says
Following what he describes as a key customer win, PI Financial analyst David Kwan is maintaining his bullish stance on Reliq Health Technologies … [Read more...] about Reliq Health has 155 per cent upside, PI says
Knight Therapeutics stock has 30 per cent upside, Mackie Research says
Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD) has a new strategic partnership under its belt, the … [Read more...] about Knight Therapeutics stock has 30 per cent upside, Mackie Research says